Results 181 to 190 of about 263,171 (350)

Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders. [PDF]

Int J Neuropsychopharmacol
Torsvik A, Trentani A, Stokowy TK, Skrede S, Joa I, Klæbo Reitan SM, Rettenbacher M, Kroken RA, Johnsen E, Steen VM.   +9 more
europepmc   +1 more source

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero, Mohsen Hadian, Juan Camilo Vargas‐Gonzalez, Marta Monteiro, David Gold, Abeer Khoja, Alonso Morales‐Rivero, Blas Couto, David Tang‐Wai, Susan Fox, Gabor G. Kovacs, Anthony E. Lang, Maria Carmela Tartaglia   +12 more
wiley   +1 more source

Caregivers' Preference for Antipsychotic Medication for Youth Less Than 18 Years-Old: A Discrete Choice Experiment Pilot. [PDF]

Patient Prefer Adherence
Fu YH, Bozzi LM, Butler B, dosReis S.
europepmc   +1 more source

Specific Cultural Myths Impacting Antipsychotic Drug Adherence: Reclaiming Healthy Thinking Through Emotional Recovery. [PDF]

Schizophr Bull Open
Ryan SM.
europepmc   +1 more source

Is antipsychotic medication stigmatizing for people with mental illness? [PDF]

, 2009
Jenkins, Janis H, Sajatovic, Martha
core  

Atypical antipsychotics, more than just an antipsychotic

Neural Regeneration Research, 2020
Hiram Tendilla-Beltran, Gonzalo Flores
openaire   +3 more sources

Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain

Movement Disorders, EarlyView.
Abstract Background Serotonergic and dopaminergic pathways are implicated in Parkinson's disease psychosis (PDP), but preliminary evidence also implicates the endocannabinoid system (ECS). Objectives We examined the association of gray matter volume loss in PDP patients with brain expression of the genes coding for CB1 (cannabinoid type 1) and CB2 ...
Sara Pisani, František Váša, Latha Velayudhan, Sagnik Bhattacharyya   +3 more
wiley   +1 more source

Next-step treatment for schizophrenia non-responsive to antipsychotics: a systematic review and network meta-analysis. [PDF]

EClinicalMedicine
Furukawa Y, Salahuddin NH, Wei Y, Pinioti E, Kim DD, Milosavlijević F, Siafis S, Schneider-Thoma J, Samara M, Bighelli I, Leucht S.   +10 more
europepmc   +1 more source

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

Psychotherapy and Psychosomatics, 2017
G. Chouinard, A. Samaha, V. Chouinard, C. Peretti, N. Kanahara, M. Takase, M. Iyo   +6 more
semanticscholar   +1 more source

Temporal Interference Stimulation Modulates Resting State Functional Connectivity of Motor Circuit in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Transcranial temporal interference stimulation (TIs) targeting the subthalamic nucleus (STN) is a novel noninvasive neuromodulation approach with potential to improve motor symptoms in Parkinson's disease (PD). However, its underlying neuroimaging mechanisms remain unclear.
Yongxin Xu, Chenhao Yang, Yichao Du, Xiaonan Shen, Tingting Li, Yufeng Zhang, Zijun Lu, Jie Zhuang, Nan Chen, Yulian Zhu, Chencheng Zhang, Jiaojiao Lü, Lingyan Huang, Lu Li, Jianqiang Lü, Zhenyu Qian, Zhen Wang, Jian Zhang, Junhong Zhou, Yu Liu   +19 more
wiley   +1 more source